img

Global Motion Sickness Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Motion Sickness Treatment Market Research Report 2024

Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
According to MRAResearch’s new survey, global Motion Sickness Treatment market is projected to reach US$ 653 million in 2033, increasing from US$ 552.1 million in 2022, with the CAGR of 2.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Motion Sickness Treatment market research.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Motion Sickness Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Segment by Type
Anticholinergic
Antihistamines
Others

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Motion Sickness Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Motion Sickness Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Motion Sickness Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Treatment Market Perspective (2018-2033)
2.2 Motion Sickness Treatment Growth Trends by Region
2.2.1 Global Motion Sickness Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Motion Sickness Treatment Historic Market Size by Region (2018-2023)
2.2.3 Motion Sickness Treatment Forecasted Market Size by Region (2024-2033)
2.3 Motion Sickness Treatment Market Dynamics
2.3.1 Motion Sickness Treatment Industry Trends
2.3.2 Motion Sickness Treatment Market Drivers
2.3.3 Motion Sickness Treatment Market Challenges
2.3.4 Motion Sickness Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Treatment Players by Revenue
3.1.1 Global Top Motion Sickness Treatment Players by Revenue (2018-2023)
3.1.2 Global Motion Sickness Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Motion Sickness Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Motion Sickness Treatment Revenue
3.4 Global Motion Sickness Treatment Market Concentration Ratio
3.4.1 Global Motion Sickness Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Motion Sickness Treatment Revenue in 2022
3.5 Motion Sickness Treatment Key Players Head office and Area Served
3.6 Key Players Motion Sickness Treatment Product Solution and Service
3.7 Date of Enter into Motion Sickness Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Motion Sickness Treatment Breakdown Data by Type
4.1 Global Motion Sickness Treatment Historic Market Size by Type (2018-2023)
4.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2024-2033)
5 Motion Sickness Treatment Breakdown Data by Application
5.1 Global Motion Sickness Treatment Historic Market Size by Application (2018-2023)
5.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Motion Sickness Treatment Market Size (2018-2033)
6.2 North America Motion Sickness Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Motion Sickness Treatment Market Size by Country (2018-2023)
6.4 North America Motion Sickness Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Motion Sickness Treatment Market Size (2018-2033)
7.2 Europe Motion Sickness Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Motion Sickness Treatment Market Size by Country (2018-2023)
7.4 Europe Motion Sickness Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Motion Sickness Treatment Market Size (2018-2033)
8.2 Asia-Pacific Motion Sickness Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Motion Sickness Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Motion Sickness Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Motion Sickness Treatment Market Size (2018-2033)
9.2 Latin America Motion Sickness Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Motion Sickness Treatment Market Size by Country (2018-2023)
9.4 Latin America Motion Sickness Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Motion Sickness Treatment Market Size (2018-2033)
10.2 Middle East & Africa Motion Sickness Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Motion Sickness Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Motion Sickness Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Motion Sickness Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Perrigo Company
11.2.1 Perrigo Company Company Detail
11.2.2 Perrigo Company Business Overview
11.2.3 Perrigo Company Motion Sickness Treatment Introduction
11.2.4 Perrigo Company Revenue in Motion Sickness Treatment Business (2018-2023)
11.2.5 Perrigo Company Recent Development
11.3 Prestige Brands
11.3.1 Prestige Brands Company Detail
11.3.2 Prestige Brands Business Overview
11.3.3 Prestige Brands Motion Sickness Treatment Introduction
11.3.4 Prestige Brands Revenue in Motion Sickness Treatment Business (2018-2023)
11.3.5 Prestige Brands Recent Development
11.4 WellSpring Pharmaceutical Corporation
11.4.1 WellSpring Pharmaceutical Corporation Company Detail
11.4.2 WellSpring Pharmaceutical Corporation Business Overview
11.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Introduction
11.4.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2018-2023)
11.4.5 WellSpring Pharmaceutical Corporation Recent Development
11.5 Caleb Pharmaceuticals
11.5.1 Caleb Pharmaceuticals Company Detail
11.5.2 Caleb Pharmaceuticals Business Overview
11.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Introduction
11.5.4 Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2018-2023)
11.5.5 Caleb Pharmaceuticals Recent Development
11.6 Myungmoon Pharm
11.6.1 Myungmoon Pharm Company Detail
11.6.2 Myungmoon Pharm Business Overview
11.6.3 Myungmoon Pharm Motion Sickness Treatment Introduction
11.6.4 Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2018-2023)
11.6.5 Myungmoon Pharm Recent Development
11.7 Baxter International
11.7.1 Baxter International Company Detail
11.7.2 Baxter International Business Overview
11.7.3 Baxter International Motion Sickness Treatment Introduction
11.7.4 Baxter International Revenue in Motion Sickness Treatment Business (2018-2023)
11.7.5 Baxter International Recent Development
11.8 Reliefband Technologies
11.8.1 Reliefband Technologies Company Detail
11.8.2 Reliefband Technologies Business Overview
11.8.3 Reliefband Technologies Motion Sickness Treatment Introduction
11.8.4 Reliefband Technologies Revenue in Motion Sickness Treatment Business (2018-2023)
11.8.5 Reliefband Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Motion Sickness Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Anticholinergic
Table 3. Key Players of Antihistamines
Table 4. Key Players of Others
Table 5. Global Motion Sickness Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Motion Sickness Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Motion Sickness Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Motion Sickness Treatment Market Share by Region (2018-2023)
Table 9. Global Motion Sickness Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Motion Sickness Treatment Market Share by Region (2024-2033)
Table 11. Motion Sickness Treatment Market Trends
Table 12. Motion Sickness Treatment Market Drivers
Table 13. Motion Sickness Treatment Market Challenges
Table 14. Motion Sickness Treatment Market Restraints
Table 15. Global Motion Sickness Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Motion Sickness Treatment Market Share by Players (2018-2023)
Table 17. Global Top Motion Sickness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Treatment as of 2022)
Table 18. Ranking of Global Top Motion Sickness Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Motion Sickness Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Motion Sickness Treatment Product Solution and Service
Table 22. Date of Enter into Motion Sickness Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Motion Sickness Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Motion Sickness Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Motion Sickness Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Motion Sickness Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Motion Sickness Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Motion Sickness Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Motion Sickness Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Motion Sickness Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Motion Sickness Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Motion Sickness Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Motion Sickness Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Motion Sickness Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Motion Sickness Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Motion Sickness Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Motion Sickness Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Motion Sickness Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Motion Sickness Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Motion Sickness Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Motion Sickness Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Motion Sickness Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Motion Sickness Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Motion Sickness Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Motion Sickness Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Motion Sickness Treatment Product
Table 50. GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Perrigo Company Company Detail
Table 53. Perrigo Company Business Overview
Table 54. Perrigo Company Motion Sickness Treatment Product
Table 55. Perrigo Company Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 56. Perrigo Company Recent Development
Table 57. Prestige Brands Company Detail
Table 58. Prestige Brands Business Overview
Table 59. Prestige Brands Motion Sickness Treatment Product
Table 60. Prestige Brands Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 61. Prestige Brands Recent Development
Table 62. WellSpring Pharmaceutical Corporation Company Detail
Table 63. WellSpring Pharmaceutical Corporation Business Overview
Table 64. WellSpring Pharmaceutical Corporation Motion Sickness Treatment Product
Table 65. WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 66. WellSpring Pharmaceutical Corporation Recent Development
Table 67. Caleb Pharmaceuticals Company Detail
Table 68. Caleb Pharmaceuticals Business Overview
Table 69. Caleb Pharmaceuticals Motion Sickness Treatment Product
Table 70. Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 71. Caleb Pharmaceuticals Recent Development
Table 72. Myungmoon Pharm Company Detail
Table 73. Myungmoon Pharm Business Overview
Table 74. Myungmoon Pharm Motion Sickness Treatment Product
Table 75. Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 76. Myungmoon Pharm Recent Development
Table 77. Baxter International Company Detail
Table 78. Baxter International Business Overview
Table 79. Baxter International Motion Sickness Treatment Product
Table 80. Baxter International Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 81. Baxter International Recent Development
Table 82. Reliefband Technologies Company Detail
Table 83. Reliefband Technologies Business Overview
Table 84. Reliefband Technologies Motion Sickness Treatment Product
Table 85. Reliefband Technologies Revenue in Motion Sickness Treatment Business (2018-2023) & (US$ Million)
Table 86. Reliefband Technologies Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Motion Sickness Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Motion Sickness Treatment Market Share by Type: 2022 VS 2033
Figure 3. Anticholinergic Features
Figure 4. Antihistamines Features
Figure 5. Others Features
Figure 6. Global Motion Sickness Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Motion Sickness Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Motion Sickness Treatment Report Years Considered
Figure 12. Global Motion Sickness Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Motion Sickness Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Motion Sickness Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Motion Sickness Treatment Market Share by Players in 2022
Figure 16. Global Top Motion Sickness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Motion Sickness Treatment Revenue in 2022
Figure 18. North America Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Motion Sickness Treatment Market Share by Country (2018-2033)
Figure 20. United States Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Motion Sickness Treatment Market Share by Country (2018-2033)
Figure 24. Germany Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Motion Sickness Treatment Market Share by Region (2018-2033)
Figure 32. China Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Motion Sickness Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Motion Sickness Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Motion Sickness Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 47. Perrigo Company Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 48. Prestige Brands Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 49. WellSpring Pharmaceutical Corporation Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 50. Caleb Pharmaceuticals Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 51. Myungmoon Pharm Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 52. Baxter International Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 53. Reliefband Technologies Revenue Growth Rate in Motion Sickness Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed